HAFC:NASDAQHanmi Financial Corporation Analysis
Data as of 2026-04-07 - not real-time
$26.86
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Hanmi Financial (HAFC) is trading at $26.86, just below its short‑term resistance of $26.92 and comfortably above the support level of $24.54. The stock’s 20‑day SMA ($25.87) sits under the current price, while the 50‑day SMA ($26.57) is slightly above, indicating a marginally bullish bias. Technical momentum is reinforced by a bullish MACD histogram (+0.17) and an RSI of 58, suggesting room for upside without being overbought. The company recently announced a 4% increase in its cash dividend to $0.28 per share and expanded its share‑repurchase authorization, underscoring management’s confidence and appealing to income‑focused investors. Revenue grew 15.7% YoY and forward EPS is projected at $3.32, a 32% jump from trailing EPS of $2.51, supporting a growth narrative. Valuation metrics are attractive: a P/E of 10.7 versus the industry average of 16.8, a price‑to‑book of ~1.0, and a dividend yield of 4.23% with a payout ratio under 45%, indicating sustainability.
The balance sheet shows ample cash ($215.6 M) against modest debt ($319 M) and a low beta of 0.68, pointing to defensive characteristics and limited market volatility. Volatility over the past 30 days is high at 27%, but the maximum drawdown of –16% remains manageable. Analyst consensus is a “Buy” with a median target of $31.25, implying about 15% upside. Given the blend of solid earnings growth, attractive valuation, and a resilient dividend, the stock is positioned for medium‑ to long‑term appreciation while offering downside protection.
The balance sheet shows ample cash ($215.6 M) against modest debt ($319 M) and a low beta of 0.68, pointing to defensive characteristics and limited market volatility. Volatility over the past 30 days is high at 27%, but the maximum drawdown of –16% remains manageable. Analyst consensus is a “Buy” with a median target of $31.25, implying about 15% upside. Given the blend of solid earnings growth, attractive valuation, and a resilient dividend, the stock is positioned for medium‑ to long‑term appreciation while offering downside protection.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and RSI below overbought levels
- Attractive dividend yield with recent increase
- Price hovering near short‑term resistance
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to peers (low P/E, P/B)
- Revenue and EPS growth projections
- Dividend sustainability and share‑repurchase program
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong cash position and low leverage
- Low beta indicating defensive profile
- Consistent dividend income and growth potential
Key Metrics & Analysis
Financial Health
Revenue Growth15.70%
Profit Margin29.75%
P/E Ratio10.7
ROE9.96%
ROA0.98%
P/B Ratio1.0
Op. Cash Flow$206.0M
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI58.0
Support$24.54
Resistance$26.92
MA 20$25.87
MA 50$26.57
MA 200$26.01
MACDBullish
VolumeDecreasing
Fear & Greed Index77.59
Valuation
Fair Value$120.67
Target Price$31.00
Upside/Downside15.41%
GradeUndervalued
TypeBlend
Dividend Yield4.23%
Risk Assessment
Beta0.68
Volatility27.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.